ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IQAI Iq-ai Limited

1.35
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Iq-ai Limited LSE:IQAI London Ordinary Share JE00BD4H0R42 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.35 1.30 1.40 1.35 1.285 1.35 520,145 08:00:03
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Florists 536k -512k -0.0028 -4.82 2.47M
Iq-ai Limited is listed in the Florists sector of the London Stock Exchange with ticker IQAI. The last closing price for Iq-ai was 1.35p. Over the last year, Iq-ai shares have traded in a share price range of 1.285p to 5.75p.

Iq-ai currently has 182,621,390 shares in issue. The market capitalisation of Iq-ai is £2.47 million. Iq-ai has a price to earnings ratio (PE ratio) of -4.82.

Iq-ai Share Discussion Threads

Showing 3626 to 3645 of 9050 messages
Chat Pages: Latest  146  145  144  143  142  141  140  139  138  137  136  135  Older
DateSubjectAuthorDiscuss
02/3/2020
10:10
htps://pubs.rsna.org/doi/10.1148/radiol.2020200642

This is the journal entry add the t next to p

spurs90
02/3/2020
10:06
Any links to cv 19 Spurs ?
dave4545
02/3/2020
10:04
Buyers buying!!!! Moves quick
spurs90
29/2/2020
13:55
February 28, 2020 — New healthcare technologies are being implemented in the fight against the novel coronavirus (COVID-19) outbreak in China. This new tech includes artificial intelligence, analytics software, and using drones to make deliveries to hospitals, according to the healthcare market research firm GlobalData.

htps://www.itnonline.com/article/emerging-technologies-proving-value-chinese-coronavirus-fighthxxps://www.dicardiology.com/article/emerging-technologies-proving-value-chinese-coronavirus-fight

spurs90
29/2/2020
13:40
February 26, 2020 — In a study of more than 1,000 patients published in the journal Radiology, chest CT outperformed lab testing in the diagnosis of 2019 novel coronavirus disease (COVID-19). The researchers concluded that CT should be used as the primary screening tool for COVID-19

htps://www.itnonline.com/content/ct-provides-best-diagnosis-novel-coronavirus-covid-19

spurs90
27/2/2020
15:08
DOW,FTSE getting hammered again does not help, tin hats and all that!
hulk2004
27/2/2020
15:07
Spurs agree lots going on with IB and all positive,2 new consultants this year, one x FDBK, plenty of cash in the bank but this slow share price drip is painful if watching daily!
hulk2004
27/2/2020
13:22
For all doubting BIG NEWS ON THE WAY

WATCH THE LAST INTERVIEW ON PROACTIVE INVESTORS FROM 2 minutes 38 seconds


MAJOR CANCER SCIENCE WRAPPING UP BY END OF FIRST QUARTER

spurs90
26/2/2020
20:19
I like huge!
hulk2004
26/2/2020
19:43
Going huge
turbotrader2
26/2/2020
17:35
htps://www.ismrm.org/virtual-meetings/

Kathleen Schmainda presenting at the Mar 5 ISMRM Perfusion Study Group Virtual Meeting: Frontiers in Perfusion MRI: Dynamic Susceptibility Contrast Perfusion MRI: An Update on Clinical Applications in Brain Tumors.

Now watch the last interview from 2.38 Michael says wrapping up major cancer science by end of q1

htps://www.proactiveinvestors.co.uk/companies/news/910735/more-from-imaging-biometrics-on-the-ai-deal-910735.html

spurs90
26/2/2020
15:08
Because he's 'Top AIM Stocks' and he's long from 10p and staring down the barrel of yet another massive loss. The best thing about his twitter feed is his fantastic ability to pick out stocks for everyone to go short on.
dplewis1
23/2/2020
14:47
Why you spamming
turbotrader2
21/2/2020
16:30
Barrow Neurological Institute / Dignity Health St. Joseph's Hospital and Medical Center has led the way in the development of cutting-edge diagnosis, treatment, and neurosurgical procedures for patients with brain tumors. Every year, Barrow treats thousands of patients with brain tumors, including some of the most difficult cases in the world. Since 1962, Barrow has grown into one of the premiere destinations in the world for neurology and neurosurgery. Experienced, highly skilled, and comprehensive teams of neurological specialists provide a complete spectrum of care-from diagnosis through outpatient neurorehabilitation-under one roof. Barrow Neurological Institute: Discover. Educate. Heal.
spurs90
21/2/2020
16:29
From dec 18 rns
IB Rad Tech offers customised workflows that automate the generation of sophisticated maps, outputs quality assurance indices, and can allow manual acknowledgement and intervention during intermediate processing steps. For example, one workflow used in generating quantitative Delta T1 and FTB maps relies on an exclusive machine-learned calibration technology termed "standardisation", which works for all platforms and field strengths. This step has proven superior to conventional normalisation techniques as it eliminates the need for the manual placement of regions of interest (ROIs) by radiology staff or physicians thereby reducing error and improving workflow efficiencies.

David Smith, CEO of IB, said, "Using this automated normalisation algorithm within an IB Rad Tech workflow enables objective longitudinal assessment and can help assess whether a certain treatment protocol is working for brain tumor patients. Removing the variability of the manually-placed ROI is a more repeatable and faster method to do inter- and intra-study comparisons for multi-center clinical trials as well."

"Without IB Rad Tech, we would not be able to process the high volume of studies we see at our site," said Dr. John Karis, MD, Director of MRI and brain imaging for the Department of Neuroradiology at Barrow Neurological Institute, Dignity Health St. Joseph's Hospital and Medical Center. "Our MR Technologists are now able to quickly and consistently generate IB's advanced maps, and the clinicians trust the science on which Delta T1 and FTBs are based", added Josef Debbins, PhD, Staff Scientist, Keller Center for Imaging Innovation at Barrow.

spurs90
21/2/2020
13:40
1 day closer to stonechecker sale! But IB will be the game changer tong term.
hulk2004
18/2/2020
10:50
Buy and hold be patient game changing news on way listen to last interview pretty clear
spurs90
18/2/2020
10:00
The drift is disappointing but I am thinking that it is now at a level worth accumulating.
greyseal
18/2/2020
09:15
This is becoming silly
turbotrader2
16/2/2020
19:36
Good to hear spurs, buy the dip so true lol
hulk2004
Chat Pages: Latest  146  145  144  143  142  141  140  139  138  137  136  135  Older

Your Recent History

Delayed Upgrade Clock